Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico–Atrial Fibrillation - GISSI-AF


Given that several studies have shown a role of the angiotensin-renin system in atrial remodeling in patients with atrial fibrillation (AF), the GISSI-AF trial sought to evaluate the safety and efficacy of adding valsartan to established therapies in patients with recurrent AF.